The company maintains a strained liquidity profile with a current ratio of 0.87 and a significant debt load of $78.3B as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 74.82B | 74.71B | 68.64B | 67.86B | 65.63B | 60.01B | 56.37B | 50.3B | 45.24B | 31.23B | 31.04B | 29.16B | 25.98B | 25.32B | 20.16B | 18.59B | 17.71B | 17.54B | 16.53B | 14.15B | 10.4B | 8.39B | 7.92B | 6.5B | 5.98B | 5.41B | 4.94B | 4.61B | 4.35B | 3.89B | 3.53B |
| Cash & Short-Term Investments | 11.8B | 10.66B | 10.99B | 11.46B | 15.72B | 12.53B | 10.85B | 8.06B | 6.58B | 1.81B | 3.46B | 2.55B | 2.52B | 4.18B | 1.38B | 1.42B | 1.43B | 1.09B | 1.35B | 1.08B | 530.7M | 513.4M | 392.3M | 843.2M | 700.4M | 236.3M | 337.3M | 230M | 181M | 192.5M | 471.8M |
| Cash Only | 9.54B | 8.51B | 8.59B | 8.2B | 12.95B | 9.41B | 7.85B | 5.68B | 4.06B | 1.7B | 3.37B | 2.46B | 2.48B | 4.09B | 1.38B | 1.41B | 1.43B | 1.09B | 1.35B | 1.06B | 530.7M | 513.4M | 392.3M | 843.2M | 700.4M | 236.3M | 337.3M | 230M | 181M | 192.5M | 471.8M |
| Short-Term Investments | 2.26B | 2.15B | 2.41B | 3.26B | 2.78B | 3.12B | 3B | 2.37B | 2.52B | 111M | 87M | 88M | 34M | 88M | 5M | 5M | 4M | 5M | 0 | 27.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 17.77B | 19.25B | 18.11B | 18.02B | 19.09B | 17.76B | 18.5B | 17.52B | 16.45B | 15.3B | 14.76B | 14B | 11.93B | 11.04B | 11.03B | 10.05B | 10.7B | 10.34B | 9.15B | 8.01B | 7.11B | 5.72B | 5.45B | 4.02B | 4.01B | 3.92B | 3.56B | 3.45B | 3.19B | 2.88B | 2.33B |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.25B | 5.03B | 3.08B | 3.15B | 3.54B | 5.29B | 5.28B | 5.11B | 4.58B | 945M | 660M | 722M | 1.85B | 1.37B | 1.27B | 1.08B | 655M | 646M | 637M | 477.5M | 374.5M | 319.9M | 309.1M | 287.2M | 248.5M | 288.8M | 217.2M | 233.2M | 328M | 364.8M | 378.2M |
| Total Non-Current Assets | 178.16B | 186.35B | 184.57B | 181.87B | 162.64B | 172.99B | 174.35B | 172.15B | 151.21B | 63.9B | 63.42B | 63.28B | 48.2B | 46.2B | 46.06B | 45.95B | 44.46B | 44.1B | 44.43B | 40.57B | 10.18B | 6.89B | 6.63B | 4.05B | 3.66B | 3.23B | 3.01B | 2.67B | 2.34B | 2.09B | 2.16B |
| Property, Plant & Equipment | 27.78B | 28.06B | 28.94B | 30.43B | 30.75B | 32.02B | 33.34B | 32.9B | 11.35B | 10.29B | 10.18B | 9.86B | 8.84B | 8.62B | 8.63B | 8.47B | 8.32B | 7.92B | 8.13B | 5.85B | 5.33B | 3.95B | 3.51B | 2.54B | 2.22B | 1.85B | 1.74B | 1.6B | 1.35B | 1.07B | 965.5M |
| Fixed Asset Turnover | 14.53x | 14.33x | 12.88x | 11.76x | 10.49x | 9.12x | 8.06x | 7.80x | 17.15x | 17.95x | 17.45x | 15.55x | 15.76x | 14.71x | 14.26x | 12.65x | 11.51x | 12.40x | 10.77x | 13.04x | 8.22x | 9.36x | 8.73x | 10.46x | 10.91x | 12.04x | 11.53x | 11.30x | 11.31x | 12.82x | 12.25x |
| Goodwill | 85.48B | 85.48B | 91.27B | 91.27B | 78.15B | 79.12B | 79.55B | 79.75B | 78.68B | 38.45B | 38.25B | 38.11B | 28.14B | 26.54B | 26.39B | 26.46B | 25.67B | 25.68B | 25.49B | 23.92B | 3.2B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 25.07B | 25.51B | 27.32B | 29.23B | 24.8B | 29.03B | 31.14B | 33.12B | 36.52B | 13.63B | 13.51B | 13.88B | 9.77B | 9.53B | 9.75B | 9.87B | 9.78B | 10.13B | 10.45B | 10.43B | 1.32B | 2.59B | 2.77B | 1.29B | 1.23B | 1.19B | 818.5M | 706.9M | 725M | 711.5M | 721.7M |
| Long-Term Investments | 127.08B | 32.87B | 28.93B | 23.02B | 21.1B | 23.02B | 20.81B | 17.31B | 15.73B | 112M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Assets | 252.97B | 261.06B | 253.22B | 249.73B | 228.28B | 233B | 230.72B | 222.45B | 196.46B | 95.13B | 94.46B | 92.44B | 74.19B | 71.53B | 66.22B | 64.54B | 62.17B | 61.64B | 60.96B | 54.72B | 20.57B | 15.28B | 14.55B | 10.54B | 9.65B | 8.64B | 7.95B | 7.28B | 6.69B | 5.98B | 5.69B |
| Asset Turnover | 1.59x | 1.54x | 1.47x | 1.43x | 1.41x | 1.25x | 1.16x | 1.15x | 0.99x | 1.94x | 1.88x | 1.66x | 1.88x | 1.77x | 1.86x | 1.66x | 1.54x | 1.59x | 1.43x | 1.39x | 2.13x | 2.42x | 2.10x | 2.52x | 2.51x | 2.58x | 2.53x | 2.49x | 2.28x | 2.30x | 2.08x |
| Asset Growth % | 5.55% | 3.1% | 1.4% | 9.4% | -2.03% | 0.99% | 3.72% | 13.23% | 106.51% | 0.71% | 2.19% | 24.6% | 3.72% | 8.01% | 2.6% | 3.82% | 0.86% | 1.12% | 11.4% | 165.97% | 34.62% | 5.06% | 37.97% | 9.31% | 11.68% | 8.64% | 9.27% | 8.82% | 11.83% | 5.01% | 43.72% |
| Total Current Liabilities | 86.41B | 88.69B | 84.61B | 79.19B | 69.42B | 67.81B | 62.02B | 53.3B | 44.01B | 30.65B | 26.25B | 23.17B | 19.03B | 15.43B | 14.15B | 11.96B | 11.07B | 12.3B | 13.49B | 10.77B | 7B | 4.58B | 4.86B | 3.49B | 3.11B | 3.07B | 2.96B | 2.89B | 3.13B | 2.91B | 2.12B |
| Accounts Payable | 16.92B | 59.38B | 15.89B | 14.9B | 14.84B | 12.54B | 11.14B | 10.49B | 8.93B | 8.86B | 7.95B | 7.49B | 6.55B | 5.55B | 5.07B | 4.37B | 4.03B | 3.56B | 3.8B | 3.59B | 2.52B | 2.47B | 2.28B | 1.67B | 1.71B | 1.54B | 1.35B | 1.45B | 1.29B | 1.23B | 1.05B |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 2.58B | 5.8B | 5.74B | 2.97B | 1.78B | 4.21B | 5.44B | 3.78B | 1.99B | 4.82B | 1.92B | 1.2B | 1.26B | 561M | 695M | 806M | 1.41B | 2.42B | 3.7B | 2.13B | 2.19B | 595M | 916.2M | 323.2M | 36.8M | 262.2M | 611.2M | 468.3M | 786M | 466.4M | 0 |
| Deferred Revenue (Current) | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Liabilities | 1.07B | 23.42B | 1.18B | 2.47B | 2.82B | 5.6B | 5.83B | 4.82B | 4.88B | 23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.48B | 346.3M | 0 | 0 | 0 | 0 | 0 | 1B | 967.4M | 1.06B | 1.21B | 1.08B |
| Current Ratio | 0.87x | 0.84x | 0.81x | 0.86x | 0.95x | 0.88x | 0.91x | 0.94x | 1.03x | 1.02x | 1.18x | 1.26x | 1.37x | 1.64x | 1.42x | 1.56x | 1.60x | 1.43x | 1.23x | 1.31x | 1.48x | 1.83x | 1.63x | 1.86x | 1.93x | 1.77x | 1.67x | 1.59x | 1.39x | 1.34x | 1.66x |
| Quick Ratio | 0.66x | 0.63x | 0.60x | 0.63x | 0.67x | 0.62x | 0.61x | 0.62x | 0.65x | 0.52x | 0.62x | 0.65x | 0.74x | 0.93x | 0.65x | 0.71x | 0.63x | 0.58x | 0.55x | 0.57x | 0.47x | 0.58x | 0.51x | 0.71x | 0.63x | 0.49x | 0.47x | 0.40x | 0.37x | 0.35x | 0.57x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 88.93B | 96.99B | 92.88B | 93.9B | 87.08B | 89.81B | 99B | 104.98B | 93.9B | 26.79B | 31.38B | 32.06B | 17.2B | 18.16B | 14.42B | 14.54B | 13.37B | 13.57B | 12.9B | 12.63B | 3.65B | 2.37B | 2.7B | 1.03B | 1.34B | 1B | 680.8M | 705.8M | 442M | 453.7M | 1.37B |
| Long-Term Debt | 60.53B | 72.88B | 60.53B | 58.64B | 50.48B | 51.97B | 59.21B | 64.7B | 71.44B | 22.18B | 25.61B | 26.27B | 11.63B | 12.84B | 9.13B | 9.21B | 8.65B | 8.76B | 8.06B | 8.35B | 2.87B | 1.59B | 1.93B | 753.1M | 1.08B | 810.4M | 536.8M | 558.5M | 276M | 288.9M | 1.18B |
| Capital Lease Obligations | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Deferred Tax Liabilities | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | 175.34B | 185.68B | 177.49B | 173.09B | 156.51B | 157.62B | 161.01B | 158.28B | 137.91B | 57.44B | 57.63B | 55.23B | 36.22B | 33.59B | 28.57B | 26.49B | 24.43B | 25.87B | 26.39B | 23.4B | 10.66B | 6.95B | 7.56B | 4.52B | 4.45B | 4.07B | 3.64B | 3.6B | 3.58B | 3.36B | 3.5B |
| Total Debt | 78.34B | 93.59B | 82.92B | 79.39B | 70.73B | 76B | 85.04B | 89B | 73.43B | 27B | 27.53B | 27.46B | 12.89B | 13.4B | 9.83B | 10.01B | 10.06B | 11.18B | 11.75B | 10.48B | 5.06B | 2.19B | 2.84B | 1.08B | 1.11B | 1.07B | 1.15B | 1.03B | 1.06B | 755.3M | 1.18B |
| Net Debt | 68.8B | 85.08B | 74.33B | 71.19B | 57.79B | 66.59B | 77.19B | 83.32B | 69.37B | 25.31B | 24.16B | 25B | 10.41B | 9.31B | 8.45B | 8.6B | 8.63B | 10.09B | 10.4B | 9.43B | 4.53B | 1.68B | 2.45B | 233.1M | 412.7M | 836.3M | 810.7M | 796.8M | 881M | 562.8M | 712.5M |
| Debt / Equity | 1.01x | 1.24x | 1.09x | 1.04x | 0.99x | 1.01x | 1.22x | 1.39x | 1.25x | 0.72x | 0.75x | 0.74x | 0.34x | 0.35x | 0.26x | 0.26x | 0.27x | 0.31x | 0.34x | 0.33x | 0.51x | 0.26x | 0.41x | 0.18x | 0.21x | 0.23x | 0.27x | 0.28x | 0.34x | 0.29x | 0.54x |
| Debt / EBITDA | 7.44x | 6.24x | 6.32x | 4.38x | 5.81x | 4.27x | 4.63x | 5.44x | 10.90x | 2.25x | 2.14x | 2.37x | 1.20x | 1.35x | 1.10x | 1.27x | 1.32x | 1.43x | 1.61x | 1.78x | 1.59x | 0.84x | 1.50x | 0.61x | 0.73x | 0.98x | 0.71x | 0.73x | 0.90x | 0.80x | 1.37x |
| Net Debt / EBITDA | 6.53x | 5.68x | 5.67x | 3.93x | 4.75x | 3.74x | 4.21x | 5.09x | 10.29x | 2.11x | 1.88x | 2.16x | 0.97x | 0.94x | 0.94x | 1.09x | 1.13x | 1.29x | 1.42x | 1.60x | 1.43x | 0.64x | 1.29x | 0.13x | 0.27x | 0.77x | 0.50x | 0.56x | 0.75x | 0.59x | 0.82x |
| Interest Coverage | 2.11x | 1.68x | 3.08x | 5.20x | 3.55x | 5.21x | 4.36x | 3.96x | 1.54x | 8.79x | 9.00x | 11.03x | 13.48x | 15.56x | 12.24x | 10.77x | 11.39x | 12.13x | 11.45x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 77.64B | 75.38B | 75.73B | 76.64B | 71.77B | 75.38B | 69.7B | 64.17B | 58.54B | 37.7B | 36.83B | 37.2B | 37.96B | 37.94B | 37.65B | 38.05B | 37.73B | 35.77B | 34.57B | 31.32B | 9.92B | 8.33B | 6.99B | 6.02B | 5.2B | 4.57B | 4.3B | 3.68B | 3.11B | 2.61B | 2.2B |
| Equity Growth % | 0.81% | -0.46% | -1.18% | 6.78% | -4.79% | 8.15% | 8.62% | 9.61% | 55.31% | 2.34% | -0.99% | -2% | 0.07% | 0.76% | -1.05% | 0.84% | 5.5% | 3.45% | 10.38% | 215.82% | 19.04% | 19.24% | 16.03% | 15.87% | 13.8% | 6.09% | 16.98% | 18.28% | 18.99% | 19.04% | 33.69% |
| Book Value per Share | 60.70 | 59.31 | 60.01 | 59.41 | 54.25 | 56.72 | 53.04 | 49.17 | 56.08 | 36.81 | 34.14 | 33.04 | 32.47 | 30.94 | 29.42 | 28.25 | 27.40 | 24.67 | 23.54 | 22.83 | 11.62 | 9.90 | 8.50 | 7.45 | 6.41 | 5.73 | 5.39 | 4.50 | 3.84 | 3.31 | 5.15 |
| Total Shareholders' Equity | 77.46B | 75.21B | 75.56B | 76.46B | 71.47B | 75.08B | 69.39B | 63.86B | 58.23B | 37.69B | 36.83B | 37.2B | 37.96B | 37.94B | 37.65B | 38.05B | 37.7B | 35.77B | 34.57B | 31.32B | 9.92B | 8.33B | 6.99B | 6.02B | 5.2B | 4.57B | 4.3B | 3.68B | 3.11B | 2.61B | 2.2B |
| Common Stock | 50.68B | 18M | 18M | 48.99B | 48.19B | 47.38B | 46.51B | 45.97B | 45.44B | 32.1B | 17M | 17M | 17M | 17M | 17M | 16M | 16M | 16M | 16M | 15.9M | 8.5M | 8.4M | 8.3M | 4.1M | 4.1M | 4.1M | 4.1M | 4M | 4M | 0 | 0 |
| Retained Earnings | 63.28B | 61.2B | 62.84B | 61.6B | 56.4B | 54.91B | 49.64B | 45.11B | 40.91B | 43.56B | 38.98B | 35.51B | 31.85B | 28.49B | 25B | 22.09B | 19.3B | 16.36B | 13.1B | 10.29B | 7.97B | 6.74B | 5.65B | 4.85B | 4.1B | 3.49B | 3.18B | 2.54B | 2.02B | 1.73B | 1.59B |
| Treasury Stock | -36.71B | -36.79B | -36.82B | -33.84B | -31.86B | -28.17B | -28.18B | -28.23B | -28.23B | -37.8B | -33.48B | -28.92B | -24.11B | -20.2B | -16.3B | -12.01B | -9.03B | -7.61B | -5.81B | -5.62B | -314.5M | -356.5M | -385.9M | -428.6M | -469.5M | -510.8M | -404.9M | -258.5M | -260M | 0 | 0 |
| Accumulated OCI | 201M | 406M | -120M | -297M | -1.26B | 965M | 1.41B | 1.02B | 102M | -165M | -305M | -358M | -217M | -149M | -181M | -172M | -143M | -135M | -143M | -395.5M | -154.7M | -204.3M | -196.4M | -200.1M | -239M | -219.9M | -240.6M | -257M | -271M | 0 | 0 |
| Minority Interest | 181M | 168M | 170M | 175M | 300M | 306M | 312M | 306M | 318M | 4M | 4M | 7M | 5M | 0 | 0 | 30M | 34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High leverage and goodwill
As reported in recent financial statements, CVS carries a significant debt load of $78.3B as of 2026Q1, resulting in a debt-to-equity ratio of 1.01, which reflects the company's aggressive, debt-financed transition into a vertically integrated healthcare provider through large-scale acquisitions like Aetna and Oak Street Health.
The company's reliance on debt to fund its transformation strategy leaves it sensitive to interest rate fluctuations and limits its financial flexibility. Investors should monitor whether the current debt levels can be serviced effectively given the thin net margins and the ongoing volatility in medical utilization rates.
Based on the provided quarterly data, CVS maintains a substantial goodwill balance of $85.5B, which represents a significant portion of its $253.0B in total assets, suggesting that the company's valuation is heavily dependent on the successful integration and future performance of its recent healthcare service acquisitions.
The high concentration of intangible assets warrants investigation into potential impairment risks, particularly if the primary care and insurance segments fail to meet growth targets. This asset mix highlights the company's shift toward a service-oriented model, though it introduces volatility into the balance sheet's underlying value.
According to recent SEC filings, CVS's current ratio has remained consistently below 1.0, standing at 0.87 in 2026Q1, which indicates that the company's short-term assets may be insufficient to cover its immediate liabilities without relying on ongoing operational cash flow or external financing access.
This liquidity profile suggests a narrow margin for error, especially when considering the cyclical nature of insurance claims and pharmacy payables. The persistent sub-1.0 current ratio implies that the firm operates with minimal cash buffers, making it vulnerable to unexpected shocks in medical utilization or regulatory changes.
As indicated by the latest balance sheet data, CVS has built a solid foundation of $63.3B in retained earnings as of 2026Q1, which serves as the primary driver of its $77.5B total equity, demonstrating the firm's historical ability to generate profits despite recent margin pressures.
While the accumulation of retained earnings provides a cushion, the stability of this equity base is contingent upon the company's ability to maintain profitability in its core segments. Investors should watch for any erosion in this base, which could signal that the cost of integration is outpacing organic growth.
Based on reported figures, the significant gap between GAAP earnings and the high level of goodwill on the balance sheet suggests that headline equity figures may be overstated if the anticipated synergies from recent acquisitions do not materialize as expected in the current healthcare environment.
The reliance on intangible assets to justify the current balance sheet structure creates a risk that future impairment charges could significantly impact shareholder equity. This non-obvious risk makes the headline leverage metrics appear more manageable than they might be if the acquired assets underperform their original valuation models.
Quick answers to the most common questions about buying CVS stock.
As of 2025, CVS Health Corporation (CVS) had total assets of $261.06B including $74.71B in current assets.
CVS Health Corporation (CVS) carries total debt of $93.59B, offset by $10.66B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
CVS Health Corporation (CVS) has total shareholders' equity (book value) of $75.21B ($59.31 book value per share). Book value represents the net worth of the company belonging to common stock holders.
CVS Health Corporation (CVS) reported a current ratio of 0.84x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.